Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centene Corp (NY: CNC )

61.43 +1.06 (+1.76%)
Official Closing Price Updated: 7:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corp

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Humana Stock Defies Weak Market, Flashes Renewed Strength
Humana sees its Relative Strength Rating hit the 80-plus level. 
Via Investor's Business Daily
Looking Into Centene's Recent Short Interest
Centene's (NYSE:CNC) short percent of float has risen 7.87% since its last report. The company recently reported that it has 7.85 million shares sold short, which is 1.37% of all... 
Via Benzinga
Here's How Much $1000 Invested In Centene 5 Years Ago Would Be Worth Today
Centene (NYSE:CNC) has outperformed the market over the past 5 years by 5.11% on an annualized basis producing an average annual return of 14.96%. Currently, Centene has a market capitalization of... 
Via Benzinga
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much
Centene (NYSE:CNC) has outperformed the market over the past 15 years by 12.83% on an annualized basis producing an average annual return of 19.78%. Currently, Centene has a market capitalization of... 
Via Benzinga
What 4 Analyst Ratings Have To Say About Centene
Over the past 3 months, 4 analysts have published their opinion on Centene (NYSE:CNC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Upgrades 
Via Benzinga
Behavioral Health Center of Excellence and Centene Announce Partnership to Advance Quality in Autism Treatment Outcomes
From Behavioral Health Center of Excellence
Via Business Wire
Cigna Stock Clears Key Benchmark, Hitting 90-Plus RS Rating
Managed care Cigna stock had its Relative Strength (RS) Rating upgraded from to 92 Friday from 89 a day earlier. 
Via Investor's Business Daily
Centene Offloads Two Pharmacy Businesses For $2.8B
Centene Corporation (NYSE: CNC) has agreed to sell Magellan Rx to Prime Therapeutics LLC and PANTHERx Rare to a consortium of The Vistria... 
Via Benzinga
General Motors And 3 Other Stocks Insiders Are Selling
US stock futures traded higher ahead of the much-awaited interest rate decision from the Federal Reserve. Investors, meanwhile, focused on some notable insider trades. When... 
Via Benzinga
Skylight Health Group Focusing On A More Holistic Approach
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Prevention is better than cure. 
Via Benzinga
Centene Posts Street Beating Q1 Earnings, Lifts FY22 Outlook
Via Benzinga
Recap: Centene Q1 Earnings
Centene (NYSE:CNC) reported its Q1 earnings results on Tuesday, April 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For April 26, 2022
Companies Reporting Before The Bell • First American Financial (NYSE:FAF) is estimated to report quarterly loss at $0.09 per share on revenue of $46.41 million. 
Via Benzinga
All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here
It's not for certain CLOV stock spikes after its upcoming earnings report, and a lot needs to happen for it to make a true price recovery. 
Via InvestorPlace
What Centene’s Next Era in Managed Care Looks Like
New Centene CEO Sarah London faces pressure from activists to increase profits, and from government to deliver more care. 
Via InvestorPlace
Biden To Propose Change To Obamacare To Extend Subsidies For Families: WSJ
Via Benzinga
House Passes Bill To Cap Out-of-Pocket Insulin Costs To No More Than $35/Month
The House of Representatives voted to approve legislation that would limit cost-sharing for insulin under private health insurance and Medicare.  
Via Benzinga
Recap: Centene Q4 Earnings
  Centene (NYSE:CNC) reported its Q4 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
Stock Market Rally Stalls As Inflation, Treasury Yields Soar: Weekly Review
The stock market rally remains stuck in a recent range as the major indexes slashed weekly gains on hot inflation. Treasury yields surged. 
Via Investor's Business Daily
Analyst Ratings For Centene
Over the past 3 months, 9 analysts have published their opinion on Centene (NYSE:CNC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's... 
Via Benzinga
CVS Health Earnings Beat But Guidance Is Tepid; CVS Stock Slips
CVS earnings topped estimates, though guidance implies an EPS dip in 2022. 
Via Investor's Business Daily
Centene Shares Jump On Better Than Expected Q4 Earnings, Reaffirms FY22 Guidance
Centene Corporation (NYSE: CNC) has reported Q4 adjusted EPS of $1.01, 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of Earnings Reports
Pre-open movers 
Via Benzinga
5 Stocks To Watch For February 8, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $0.87 per share on revenue of $24.20 billion before the opening... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Teladoc Stock Is Due for a Major Upside Reversal
Teladoc is worth at least $110 a share assuming its revenue grows at historical rates for the next few years. 
Via InvestorPlace
Earnings Scheduled For February 8, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion. 
Via Benzinga
5 Stocks Insiders Are Selling: Accenture, Centene And More
French CAC 40 Index gained around 1% this morning, partially recovering from previous session’s 4% plunge, as investors await the policy decision from the Federal Reserve... 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.